ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3 | 0.0% | 42 | +2.4% | 0.00% | 0.0% |
| Q4 2022 | $3 | -99.8% | 41 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | -60.0% | 41 | -46.1% | 0.00% | -50.0% |
| Q2 2022 | $5,000 | 0.0% | 76 | -1.3% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | +25.0% | 77 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $4,000 | -33.3% | 77 | -21.4% | 0.00% | -50.0% |
| Q3 2021 | $6,000 | +100.0% | 98 | +78.2% | 0.00% | +100.0% |
| Q2 2021 | $3,000 | 0.0% | 55 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | 0.0% | 55 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | +50.0% | 55 | +57.1% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | -33.3% | 35 | -37.5% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | +50.0% | 56 | +60.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -99.8% | 35 | -99.8% | 0.00% | -99.9% |
| Q3 2014 | $1,072,000 | -37.9% | 15,004 | -35.5% | 0.69% | -32.2% |
| Q2 2014 | $1,727,000 | – | 23,244 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |